Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism H Zhao, L Yang, J Baddour, A Achreja, V Bernard, T Moss, JC Marini, ... elife 5, e10250, 2016 | 899 | 2016 |
Homotypic fusion of ER membranes requires the dynamin-like GTPase atlastin G Orso, D Pendin, S Liu, J Tosetto, TJ Moss, JE Faust, M Micaroni, ... Nature 460 (7258), 978-983, 2009 | 515 | 2009 |
SNARE proteins are required for macroautophagy U Nair, A Jotwani, J Geng, N Gammoh, D Richerson, WL Yen, J Griffith, ... Cell 146 (2), 290-302, 2011 | 498 | 2011 |
Targeting stromal glutamine synthetase in tumors disrupts tumor microenvironment-regulated cancer cell growth L Yang, A Achreja, TL Yeung, LS Mangala, D Jiang, C Han, J Baddour, ... Cell metabolism 24 (5), 685-700, 2016 | 408 | 2016 |
Metabolic shifts toward glutamine regulate tumor growth, invasion and bioenergetics in ovarian cancer L Yang, T Moss, LS Mangala, J Marini, H Zhao, S Wahlig, G Armaiz‐Pena, ... Molecular systems biology 10 (5), 728, 2014 | 374 | 2014 |
Comprehensive genomic characterization of upper tract urothelial carcinoma TJ Moss, Y Qi, L Xi, B Peng, TB Kim, NE Ezzedine, ME Mosqueda, ... European urology 72 (4), 641-649, 2017 | 213 | 2017 |
A deep learning framework for predicting response to therapy in cancer T Sakellaropoulos, K Vougas, S Narang, F Koinis, A Kotsinas, A Polyzos, ... Cell reports 29 (11), 3367-3373. e4, 2019 | 203 | 2019 |
Upper tract urothelial carcinoma has a luminal-papillary T-cell depleted contexture and activated FGFR3 signaling BD Robinson, PJ Vlachostergios, B Bhinder, W Liu, K Li, TJ Moss, ... Nature communications 10 (1), 2977, 2019 | 195 | 2019 |
A switch in the source of ATP production and a loss in capacity to perform glycolysis are hallmarks of hepatocyte failure in advance liver disease T Nishikawa, N Bellance, A Damm, H Bing, Z Zhu, K Handa, MI Yovchev, ... Journal of hepatology 60 (6), 1203-1211, 2014 | 148 | 2014 |
The glucose‐deprivation network counteracts lapatinib‐induced toxicity in resistant ErbB2‐positive breast cancer cells K Komurov, JT Tseng, M Muller, EG Seviour, TJ Moss, L Yang, D Nagrath, ... Molecular systems biology 8 (1), 596, 2012 | 131 | 2012 |
Cupid: simultaneous reconstruction of microRNA-target and ceRNA networks HS Chiu, D Llobet-Navas, X Yang, WJ Chung, A Ambesi-Impiombato, ... Genome research 25 (2), 257-267, 2015 | 113 | 2015 |
Membrane fusion by the GTPase atlastin requires a conserved C-terminal cytoplasmic tail and dimerization through the middle domain TJ Moss, C Andreazza, A Verma, A Daga, JA McNew Proceedings of the National Academy of Sciences 108 (27), 11133-11138, 2011 | 96 | 2011 |
Direct upregulation of STAT3 by MicroRNA-551b-3p deregulates growth and metastasis of ovarian cancer P Chaluvally-Raghavan, KJ Jeong, S Pradeep, AM Silva, S Yu, W Liu, ... Cell reports 15 (7), 1493-1504, 2016 | 92 | 2016 |
The ZNF304-integrin axis protects against anoikis in cancer B Aslan, P Monroig, MC Hsu, GA Pena, C Rodriguez-Aguayo, ... Nature communications 6 (1), 7351, 2015 | 65 | 2015 |
In Arabidopsis, the spatial and dynamic organization of the endoplasmic reticulum and Golgi apparatus is influenced by the integrity of the C‐terminal domain of RHD3, a non … G Stefano, L Renna, T Moss, JA McNew, F Brandizzi The Plant Journal 69 (6), 957-966, 2012 | 65 | 2012 |
Functional proteomics identifies miRNAs to target a p27/Myc/phospho-Rb signature in breast and ovarian cancer EG Seviour, V Sehgal, Y Lu, Z Luo, T Moss, F Zhang, SM Hill, W Liu, ... Oncogene 35 (6), 691-701, 2016 | 63 | 2016 |
The Atlastin C-terminal tail is an amphipathic helix that perturbs the bilayer structure during endoplasmic reticulum homotypic fusion JE Faust, T Desai, A Verma, I Ulengin, TL Sun, TJ Moss, ... Journal of Biological Chemistry 290 (8), 4772-4783, 2015 | 56 | 2015 |
Copy number gain of hsa-miR-569 at 3q26. 2 leads to loss of TP53INP1 and aggressiveness of epithelial cancers P Chaluvally-Raghavan, F Zhang, S Pradeep, MP Hamilton, X Zhao, ... Cancer Cell 26 (6), 863-879, 2014 | 55 | 2014 |
GTP-dependent packing of a three-helix bundle is required for atlastin-mediated fusion D Pendin, J Tosetto, TJ Moss, C Andreazza, S Moro, JA McNew, A Daga Proceedings of the National Academy of Sciences 108 (39), 16283-16288, 2011 | 44 | 2011 |
A randomized phase 2 study of MK-2206 versus everolimus in refractory renal cell carcinoma E Jonasch, E Hasanov, PG Corn, T Moss, KR Shaw, S Stovall, V Marcott, ... Annals of Oncology 28 (4), 804-808, 2017 | 42 | 2017 |